I agree that this site is using cookies. You can find further informations here.
X
Massoma, Patrick
7  results:
Search for persons X
?
1

Neuropilin‐2 contributes to tumor progression in preclinica..:

Bollard, Julien ; Patte, Céline ; Radkova, Kristina...
The Journal of Pathology.  249 (2019)  3 - p. 343-355 , 2019
Link: https://doi.org/10.1002/..
 
?
2

mTOR inhibitors activate PERK signaling and favor viability..:

Freis, Patricia ; Bollard, Julien ; Lebeau, Justine...
Oncotarget.  8 (2017)  13 - p. 20974-20987 , 2017
Link: https://doi.org/10.18632..
 
?
3

Prediction of response to everolimus in neuroendocrine tumo..:

Benslama, Noura ; Bollard, Julien ; Vercherat, Cécile...
Investigational New Drugs.  34 (2016)  5 - p. 654-662 , 2016
Link: https://doi.org/10.1007/..
 
?
4

The axon guidance molecule semaphorin 3F is a negative regu..:

Bollard, Julien ; Massoma, Patrick ; Vercherat, Cécile...
Oncotarget.  6 (2015)  34 - p. 36731-36745 , 2015
Link: https://doi.org/10.18632..
 
?
5

Mechanisms of local invasion in enteroendocrine tumors: Ide..:

Couderc, Christophe ; Bollard, Julien ; Couté, Yohann...
Molecular and Cellular Endocrinology.  399 (2015)  - p. 154-163 , 2015
Link: https://doi.org/10.1016/..
 
?
6

The workflow from post-mortem human brain sampling to cell ..:

Meyronet, David ; Dorey, Aline ; Massoma, Patrick...
Journal of Neural Transmission.  122 (2015)  7 - p. 975-991 , 2015
Link: https://doi.org/10.1007/..
 
?
7

mTOR inhibitors activate PERK signaling and favor viability..:

Freis, Patricia ; Bollard, Julien ; Lebeau, Justine...
info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.15469.  , 2017
Link: https://hal.science/hal-..
 
1-7